News und Analysen

EQS-News: Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Ulcerative Colitis

EQS-News: ABIVAX / Key word(s): Study results Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant ...weiterlesen

Seite: 1 | 2 | 3 | 4 | 5 | 6 | ... | 100 ►

Aktualisiert und erweitert!